Evidence map›Paper›PMID 35484825›Full record

ArticleJournal of evaluation in clinical practice2022

Treating equivalent cases differently: A comparative analysis of substance use disorder and type 2 diabetes in Norwegian treatment guidelines.

Fredrik D Moe, Henrik Berg

Abstract read
In one paragraph

Article in Journal of evaluation in clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Philosophy and the clinic: Stigma, respect and shame.Journal of evaluation in clinical practice · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Fredrik D MoeDepartment of Social Studies, Faculty of Social Sciences, University of Stavanger, Stavanger, Norway.ORCID 0000-0002-2731-024X
Henrik BergDepartment of Clinical Psychology, Faculty of Psychology, University of Bergen, Bergen, Norway.ORCID 0000-0003-4197-447X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSubstance use disorder (SUD) is often understood as a chronic illness.

aimsThis paper investigates whether SUD is treated as a chronic illness.

methodTo this aim, we have used World Health Organizations (WHO's) definition of chronic illness to conduct a comparative analysis of SUD and type 2 diabetes (T2D), which is another chronic illness.

resultsWhen analysing Norwegian treatment guidelines, we found that only the T2D guideline reflects the WHO's conceptualization of chronic illnesses. We argue that this discrepancy implies that SUD is understood as a moral and legal problem, while T2D is conceptualized as a somatic illness. We discuss how social, political and historical conditions of the possibility for understanding SUD are interwoven with normative presumptions about the clinician, patient, treatment guidelines and drug policies in a way that may impede the development of continuing care.

conclusionThe paper concludes that the delivery of treatment services is inequitable as SUD is not treated as a chronic illness.

Indexed as

Diabetes Mellitus, Type 2Substance-Related DisordersHumansWorld Health Organizationchronic illnessglobal policymakingsubstance use disordertreatment guidelinestype 2 diabetes

Identifiers

PMID35484825
PMCPMC9790317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.